US Patent Issued to Trustees of Boston University on March 17 for "Nasal epithelium gene expression signature and classifier for the prediction of lung cancer" (Massachusetts, California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,620, issued on March 17, was assigned to Trustees of Boston University (Boston).

"Nasal epithelium gene expression signature and classifier for the prediction of lung cancer" was invented by Avrum Spira (Newton, Mass.), Marc E. Lenburg (Brookline, Mass.), Joseph Perez-Rogers (San Mateo, Calif.) and Christina Anderlind (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application provides assays and methods for diagnosis and prognosis of lung cancer using expression analysis of one or more genes from a biological sample comprising nasal epithelial cells. The assays and methods are non-invasive and accurately detect the presence or a...